Back to Search
Start Over
<scp>PET</scp> and <scp>SPECT</scp> in Drug Development
- Source :
- Burger's Medicinal Chemistry and Drug Discovery
- Publication Year :
- 2010
- Publisher :
- Wiley, 2010.
-
Abstract
- Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are noninvasive molecular imaging techniques that can be used to provide functional information in the living human body. They use radiolabeled compounds that bind to specific sites on a biological target, known as radiotracers, enabling us to visualize and characterize specific aspects of a biological process. This chapter describes these techniques and how they can be utilized in the drug development process. Keywords: drug development; imaging; PET; SPECT
- Subjects :
- medicine.diagnostic_test
business.industry
Single-photon emission computed tomography
03 medical and health sciences
0302 clinical medicine
Drug development
Positron emission tomography
Biological target
030220 oncology & carcinogenesis
medicine
Molecular imaging
Nuclear medicine
business
030217 neurology & neurosurgery
Preclinical imaging
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Burger's Medicinal Chemistry and Drug Discovery
- Accession number :
- edsair.doi...........33f9a08d8195d12083c672d3f198ae63
- Full Text :
- https://doi.org/10.1002/0471266949.bmc254